Jeffrey W. Sherman - Dec 12, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP and Chief Medical Officer
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Dec 12, 2022
Transactions value $
-$3,159,692
Form type
4
Date filed
12/13/2022, 03:12 PM
Previous filing
Jun 9, 2022
Next filing
Dec 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Gift $0 -8.53K -78.22% $0.00 2.38K May 27, 2022 Direct F1
transaction HZNP Ordinary Shares Gift $0 +8.53K +16.11% $0.00 61.5K May 27, 2022 See Footnote F2
transaction HZNP Ordinary Shares Sale -$777K -6.97K -11.34% $111.44 54.5K Dec 12, 2022 See Footnote F2, F3, F4
transaction HZNP Ordinary Shares Sale -$2.38M -21.4K -20.2% $111.45 84.4K Dec 12, 2022 See footnote F3, F5, F6
holding HZNP Ordinary Shares 66.7K Dec 12, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 277 ordinary shares of the Issuer acquired by the reporting person on June 1, 2022 pursuant to an employee stock purchase program.
F2 The shares are held in the Jeffrey W. Sherman Living Trust.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2022.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.20 to $111.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.20 to $111.74 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.